Clinical studies have shown that the clearance of blood IL-6 and TNF-a by continuous renal replacement therapy can improve the prognosis of patients with AKI [39], suggesting that inflammation plays an important role in the development of AKI. The gene discussed is IL6; the disease is acute kidney injury.